Literature DB >> 22368981

Supratentorial intraventricular hemangioblastomas.

Satoru Takeuchi1, Yoshio Takasato.   

Abstract

A 33-year-old male presented with a headache. He had a history of a previous surgical procedure for excisions of cervical spine hemangioblastomas 13 years prior He had a family history of von-Hippel Lindau (VHL) disease, and a VHL mutation was identified. Brain magnetic resonance imaging showed enhanced mass lesions in both the third and right lateral ventricles as well as in the cerebellum. The lesion in the right lateral ventricle also had a cystic component. Two-staged resections of the tumors in the third and right lateral ventricles and ventriculo-peritoneal shunt were performed. A histopathological specimen was compatible with a hemangioblastoma. Supratentorial intraventricular hemangioblastomas are extremely rare. We reviewed the literature and discussed the features.

Entities:  

Mesh:

Year:  2011        PMID: 22368981

Source DB:  PubMed          Journal:  Acta Neurol Belg        ISSN: 0300-9009            Impact factor:   2.396


  4 in total

1.  Lateral ventricle haemangioblastoma: the role of perfusion scanning and embolisation in diagnosis and management.

Authors:  Ian Anderson; Ramesh Kumar; Tufail Patankar; Atul Tyagi
Journal:  BMJ Case Rep       Date:  2014-09-25

2.  Hemangioblastoma in the lateral ventricle: An extremely rare case report.

Authors:  Ruihan Pan; Jianwei Shi; Yang Xu; Fuduo Bo; Zhengxiang Luo; Yansong Zhang
Journal:  Front Oncol       Date:  2022-08-10       Impact factor: 5.738

3.  A Large Solitary Hemangioblastoma of the Lateral Ventricles: A Case Report and Literature Review.

Authors:  Alireza Tabibkhooei; Arash Fattahi; Ali Rostami
Journal:  Iran J Med Sci       Date:  2020-01

4.  Long-term follow-up and clinical course of a rare case of von Hippel-Lindau disease: A case report and review of the literature.

Authors:  Y U Zou; Jingjing Xu; Minming Zhang
Journal:  Oncol Lett       Date:  2016-03-29       Impact factor: 2.967

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.